tiprankstipranks
Trending News
More News >
Innate Pharma (IPHA)
NASDAQ:IPHA

Innate Pharma (IPHA) Revenue

Compare
128 Followers

Innate Pharma Revenue

Innate Pharma had a revenue of 4.86M in the quarter ending Jun 30, 2025, with 1660.87%. This bring the company's revenue in the last twelve months to 5.14M, Increased -59.31%. In the fiscal year ending Dec 31, 2024, Innate Pharma had annual revenue of 12.62M with -75.68% growth.
Revenue (ttm)
5.14M
Revenue Growth
-75.77%
P/S Ratio
12.85
Revenue/Employee
$69,729
Employees
181
Market Cap
$162.15M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
12.62M-39.28M-75.68%
Dec 31, 2023
51.90M-5.77M-10.01%
Dec 31, 2022
57.67M45.56M+376.17%
Dec 31, 2021
12.11M-57.66M-82.64%
Dec 31, 2020
69.77M800.00K+1.16%
Dec 31, 2019
68.97M-10.92M-13.67%
Dec 31, 2018
79.89M47.26M+144.83%
Dec 31, 2017
32.63M